AVEO PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2010 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Aveo Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q3 2022.
  • Aveo Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2022 was 34.6M shares, a 0.71% increase year-over-year.
  • Aveo Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 32.7M shares, a 52.6% increase from 2020.
  • Aveo Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 21.4M shares, a 39.2% increase from 2019.
  • Aveo Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2019 was 15.4M shares, a 17.6% increase from 2018.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 34.6M +244K +0.71% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 34.5M +141K +0.41% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 34.5M +7.05M +25.7% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 34.4M +8.13M +31% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-14
Q3 2021 34.4M +8.57M +33.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 34.4M +17M +97.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 27.4M +11.3M +70.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 26.3M +10.2M +63.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 25.8M +9.73M +60.5% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-14
Q2 2020 17.4M +1.46M +9.19% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-14
Q1 2020 16.1M +2.8M +21.1% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-14
Q4 2019 16.1M +2.72M +20.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 16.1M +4.07M +33.9% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-16
Q2 2019 15.9M +3.03M +23.6% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-16
Q1 2019 13.3M +1.4M +11.8% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-16
Q4 2018 13.4M -117M -89.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 12M -106M -89.8% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 12.9M -97.7M -88.4% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 11.9M -64.4M -84.4% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 130M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 118M +42.1M +55.6% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-14
Q2 2017 111M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-14
Q1 2017 76.2M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-14
Q3 2016 75.9M +18.8M +33.1% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-04
Q3 2015 57M +5.25M +10.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q3 2014 51.8M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q4 2012 43.4M +1.9M +4.58% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-13
Q3 2012 43.4M +413K +0.96% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-08
Q2 2012 43.3M +6.47M +17.6% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-07
Q1 2012 43.3M +5.77M +15.4% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-09
Q4 2011 41.5M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-13
Q3 2011 43M +12.1M +39.3% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 36.8M +6.03M +19.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 37.5M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 30.9M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 30.8M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.